Enhanced cytotoxicity of рhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells
Aim: To evaluate the viability of leukemic cells sensitive (L1210S) and resistant (L1210R) to cisplatin, ROS production and free cytosolic Ca²⁺ concentration under treatment with cisplatin or its combination with photoexcited fullerene C₆₀. Methods: Cell viability was assessed by the MTT reduction a...
Збережено в:
Дата: | 2015 |
---|---|
Автори: | , , , , |
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2015
|
Назва видання: | Experimental Oncology |
Теми: | |
Онлайн доступ: | http://dspace.nbuv.gov.ua/handle/123456789/145486 |
Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
Цитувати: | Enhanced cytotoxicity of рhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells / D.V. Franskevych, S.V. Prylutska, I.I. Grynyuk, D.M. Grebinyk, O.P. Matyshevska // Experimental Oncology. — 2015. — Т. 37, № 3. — С. 187-191. — Бібліогр.: 34 назв. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraineid |
irk-123456789-145486 |
---|---|
record_format |
dspace |
spelling |
irk-123456789-1454862019-01-24T01:23:23Z Enhanced cytotoxicity of рhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells Franskevych, D.V. Prylutska, S.V. Grynyuk, I.I. Grebinyk, D.M. Matyshevska, O.P. Original contributions Aim: To evaluate the viability of leukemic cells sensitive (L1210S) and resistant (L1210R) to cisplatin, ROS production and free cytosolic Ca²⁺ concentration under treatment with cisplatin or its combination with photoexcited fullerene C₆₀. Methods: Cell viability was assessed by the MTT reduction assay. Light-emitting diode lamp (2.45 J/сm2) was used for photoexcitation of intracellular accumulated fullerene C₆₀. Free cytosolic calcium concentration ([Ca²⁺]i) and ROS production in cells were estimated with the use of fluorescent probes Indo-1 and 2′,7′-dichlorodihydrofluorescein diacetate (DCF-DA), respectively. Results: It is shown that viability of L1210R cells wasn’t changed under treatment with cisplatin in concentration range 0.1–10 μg/ml. 50% and 30% decrease of L1210S cells were observed after 24 h of incubation with cisplatin at concentrations 5 and 1 μg/ml, respectively. Intensification of extranuclear cytotoxic effects (ROS production and [Ca²⁺]iincrease) after treatment with 1 μg/ml was detected in L1210S, but not in L1210R cells. The most strongly pronounced increase of ROS production and [Ca²⁺]i in both L1210 cell lines was revealed in dynamics after combined treatment with cisplatin (1 μg/ml) and photoexcited fullerene C₆₀ (10⁻⁵ M) and was followed by decreased viability of not only L1210S, but of L1210R cells as well.. Conclusion: Combined treatment with photoexcited C₆₀ and cisplatin allowed to decrease effective concentration of cisplatin against parental L1210 cells and to increase sensibility of resistant cells to the drug. Key Words: cisplatin, L1210 cells, photoexcited fullerene C₆₀, ROS, cytosolic Ca²⁺, cell viability. 2015 Article Enhanced cytotoxicity of рhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells / D.V. Franskevych, S.V. Prylutska, I.I. Grynyuk, D.M. Grebinyk, O.P. Matyshevska // Experimental Oncology. — 2015. — Т. 37, № 3. — С. 187-191. — Бібліогр.: 34 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/145486 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
institution |
Digital Library of Periodicals of National Academy of Sciences of Ukraine |
collection |
DSpace DC |
language |
English |
topic |
Original contributions Original contributions |
spellingShingle |
Original contributions Original contributions Franskevych, D.V. Prylutska, S.V. Grynyuk, I.I. Grebinyk, D.M. Matyshevska, O.P. Enhanced cytotoxicity of рhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells Experimental Oncology |
description |
Aim: To evaluate the viability of leukemic cells sensitive (L1210S) and resistant (L1210R) to cisplatin, ROS production and free cytosolic Ca²⁺ concentration under treatment with cisplatin or its combination with photoexcited fullerene C₆₀. Methods: Cell viability was assessed by the MTT reduction assay. Light-emitting diode lamp (2.45 J/сm2) was used for photoexcitation of intracellular accumulated fullerene C₆₀. Free cytosolic calcium concentration ([Ca²⁺]i) and ROS production in cells were estimated with the use of fluorescent probes Indo-1 and 2′,7′-dichlorodihydrofluorescein diacetate (DCF-DA), respectively. Results: It is shown that viability of L1210R cells wasn’t changed under treatment with cisplatin in concentration range 0.1–10 μg/ml. 50% and 30% decrease of L1210S cells were observed after 24 h of incubation with cisplatin at concentrations 5 and 1 μg/ml, respectively. Intensification of extranuclear cytotoxic effects (ROS production and [Ca²⁺]iincrease) after treatment with 1 μg/ml was detected in L1210S, but not in L1210R cells. The most strongly pronounced increase of ROS production and [Ca²⁺]i in both L1210 cell lines was revealed in dynamics after combined treatment with cisplatin (1 μg/ml) and photoexcited fullerene C₆₀ (10⁻⁵ M) and was followed by decreased viability of not only L1210S, but of L1210R cells as well.. Conclusion: Combined treatment with photoexcited C₆₀ and cisplatin allowed to decrease effective concentration of cisplatin against parental L1210 cells and to increase sensibility of resistant cells to the drug. Key Words: cisplatin, L1210 cells, photoexcited fullerene C₆₀, ROS, cytosolic Ca²⁺, cell viability. |
format |
Article |
author |
Franskevych, D.V. Prylutska, S.V. Grynyuk, I.I. Grebinyk, D.M. Matyshevska, O.P. |
author_facet |
Franskevych, D.V. Prylutska, S.V. Grynyuk, I.I. Grebinyk, D.M. Matyshevska, O.P. |
author_sort |
Franskevych, D.V. |
title |
Enhanced cytotoxicity of рhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells |
title_short |
Enhanced cytotoxicity of рhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells |
title_full |
Enhanced cytotoxicity of рhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells |
title_fullStr |
Enhanced cytotoxicity of рhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells |
title_full_unstemmed |
Enhanced cytotoxicity of рhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells |
title_sort |
enhanced cytotoxicity of рhotoexcited fullerene c60 and cisplatin combination against drug-resistant leukemic cells |
publisher |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
publishDate |
2015 |
topic_facet |
Original contributions |
url |
http://dspace.nbuv.gov.ua/handle/123456789/145486 |
citation_txt |
Enhanced cytotoxicity of рhotoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells / D.V. Franskevych, S.V. Prylutska, I.I. Grynyuk, D.M. Grebinyk, O.P. Matyshevska // Experimental Oncology. — 2015. — Т. 37, № 3. — С. 187-191. — Бібліогр.: 34 назв. — англ. |
series |
Experimental Oncology |
work_keys_str_mv |
AT franskevychdv enhancedcytotoxicityofrhotoexcitedfullerenec60andcisplatincombinationagainstdrugresistantleukemiccells AT prylutskasv enhancedcytotoxicityofrhotoexcitedfullerenec60andcisplatincombinationagainstdrugresistantleukemiccells AT grynyukii enhancedcytotoxicityofrhotoexcitedfullerenec60andcisplatincombinationagainstdrugresistantleukemiccells AT grebinykdm enhancedcytotoxicityofrhotoexcitedfullerenec60andcisplatincombinationagainstdrugresistantleukemiccells AT matyshevskaop enhancedcytotoxicityofrhotoexcitedfullerenec60andcisplatincombinationagainstdrugresistantleukemiccells |
first_indexed |
2023-05-20T17:22:17Z |
last_indexed |
2023-05-20T17:22:17Z |
_version_ |
1796153143006855168 |